Susan MBA - Tevogen Bio Independent Officer
| TVGNW Stock | 0.06 0 5.66% |
Executive
Susan MBA is Independent Officer of Tevogen Bio Holdings
| Age | 60 |
| Address | 15 Independence Boulevard, Warren, NJ, United States, 07059 |
| Phone | 877-838-6436 |
| Web | https://tevogen.com |
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Fawwad Qureshi | Trupanion | 50 | |
| Asher Bearman | Trupanion | 46 | |
| Jeremy King | 55 | ||
| Bradley Lamb | Trupanion | N/A | |
| Howard Rubin | Trupanion | 71 | |
| Karen Caddick | Siriuspoint | 55 | |
| James McKinney | Siriuspoint | 44 | |
| Julia Donnelly | 41 | ||
| MRCVS BVMS | Trupanion | 49 | |
| Shawn McWashington | Trupanion | N/A | |
| Tracey Gibbons | Siriuspoint | N/A | |
| Christine Flores | 45 | ||
| John Gallagher | Trupanion | 37 | |
| Laura Bainbridge | Trupanion | N/A | |
| Wanjiku Walcott | 53 | ||
| Brett JD | Primerica | 59 | |
| Justin Brenden | Siriuspoint | 40 | |
| Sabrina Ellis | 51 | ||
| Emily Dreyer | Trupanion | 36 | |
| Nicholas Campbell | Siriuspoint | 55 | |
| Margaret Tooth | Trupanion | 45 | |
Tevogen Bio Holdings Leadership Team
Elected by the shareholders, the Tevogen Bio's board of directors comprises two types of representatives: Tevogen Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tevogen. The board's role is to monitor Tevogen Bio's management team and ensure that shareholders' interests are well served. Tevogen Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tevogen Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Susan MBA, Independent Officer | ||
| Mittul Mehta, Chief Tevogenai | ||
| Sadiq Khan, Chief Officer | ||
| Jeffrey MPH, Member Officer | ||
| Tapan Shah, Head Development | ||
| Kirti CPA, Chief Officer | ||
| Kirti Desai, CFO Director | ||
| Sadiq MBA, Chief Officer | ||
| Neal MD, Global Officer | ||
| Stephen MBA, Chief Officer | ||
| MPH MD, CEO CoFounder | ||
| MD MPH, CEO CoFounder |
Tevogen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tevogen Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| EBITDA | 188.71 K | ||||
| Net Income | (67.33 K) | ||||
| Total Debt | 1.63 M | ||||
| Cash Flow From Operations | (1.38 M) | ||||
| Total Asset | 17.04 M | ||||
| Retained Earnings | (17.38 M) | ||||
| Working Capital | (2.65 M) | ||||
| Net Asset | 17.04 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Tevogen Stock Analysis
When running Tevogen Bio's price analysis, check to measure Tevogen Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tevogen Bio is operating at the current time. Most of Tevogen Bio's value examination focuses on studying past and present price action to predict the probability of Tevogen Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tevogen Bio's price. Additionally, you may evaluate how the addition of Tevogen Bio to your portfolios can decrease your overall portfolio volatility.